206 related articles for article (PubMed ID: 19508443)
1. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
3. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
[TBL] [Abstract][Full Text] [Related]
4. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
7. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
[TBL] [Abstract][Full Text] [Related]
8. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton.
Roelofs RF; Fischer DF; Houtman SH; Sluijs JA; Van Haren W; Van Leeuwen FW; Hol EM
Glia; 2005 Dec; 52(4):289-300. PubMed ID: 16001427
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
10. [Expression of autophagy-related proteins in malformations of cortical development].
Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
[TBL] [Abstract][Full Text] [Related]
11. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
Mao C; Jin L; Dou W; Lu Q; Zhou L; Ren H; Zhao Y; Feng F; Guo Y; Gao J
Epilepsy Res; 2019 Nov; 157():106189. PubMed ID: 31472401
[TBL] [Abstract][Full Text] [Related]
12. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
14. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
[TBL] [Abstract][Full Text] [Related]
15. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
[TBL] [Abstract][Full Text] [Related]
16. CD44 expression in tuberous sclerosis.
Arai Y; Takashima S; Becker LE
Pathobiology; 2000; 68(2):87-92. PubMed ID: 10878505
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
[TBL] [Abstract][Full Text] [Related]
18. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
[TBL] [Abstract][Full Text] [Related]
19. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.
Liu J; Reeves C; Michalak Z; Coppola A; Diehl B; Sisodiya SM; Thom M
Acta Neuropathol Commun; 2014 Jul; 2():71. PubMed ID: 25005575
[TBL] [Abstract][Full Text] [Related]
20. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]